Abiomed Stock Short Ratio
ABIOMED fundamentals help investors to digest information that contributes to ABIOMED's financial success or failures. It also enables traders to predict the movement of ABIOMED Stock. The fundamental analysis module provides a way to measure ABIOMED's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ABIOMED stock.
ABIOMED |
ABIOMED Company Short Ratio Analysis
ABIOMED's Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.
Current ABIOMED Short Ratio | 0.39 X |
Most of ABIOMED's fundamental indicators, such as Short Ratio, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, ABIOMED is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The higher the Short Ratio, the longer it would take to buy back the borrowed shares. In theory, the more short positions are currently outstanding, the faster it will be to cover shorted positions.
CompetitionBased on the latest financial disclosure, ABIOMED has a Short Ratio of 0.39 times. This is 90.0% lower than that of the Health Care Equipment & Supplies sector and 89.66% lower than that of the Health Care industry. The short ratio for all United States stocks is 90.25% higher than that of the company.
ABIOMED Short Ratio Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses ABIOMED's direct or indirect competition against its Short Ratio to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of ABIOMED could also be used in its relative valuation, which is a method of valuing ABIOMED by comparing valuation metrics of similar companies.ABIOMED is currently under evaluation in short ratio category among its peers.
ABIOMED Fundamentals
| Return On Equity | 0.18 | |||
| Return On Asset | 0.0955 | |||
| Profit Margin | 0.25 % | |||
| Operating Margin | 0.23 % | |||
| Current Valuation | 16.32 B | |||
| Shares Outstanding | 45.09 M | |||
| Shares Owned By Insiders | 2.02 % | |||
| Shares Owned By Institutions | 97.00 % | |||
| Number Of Shares Shorted | 753.62 K | |||
| Price To Earning | 76.38 X | |||
| Price To Book | 11.13 X | |||
| Price To Sales | 15.96 X | |||
| Revenue | 1.03 B | |||
| Gross Profit | 843.6 M | |||
| EBITDA | 268.49 M | |||
| Net Income | 136.5 M | |||
| Cash And Equivalents | 844.32 M | |||
| Cash Per Share | 18.57 X | |||
| Total Debt | 10 M | |||
| Debt To Equity | 0.01 % | |||
| Current Ratio | 7.53 X | |||
| Book Value Per Share | 34.09 X | |||
| Cash Flow From Operations | 285.39 M | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | 5.83 X | |||
| Price To Earnings To Growth | 2.75 X | |||
| Target Price | 363.0 | |||
| Number Of Employees | 2 K | |||
| Beta | 1.4 | |||
| Market Capitalization | 17.18 B | |||
| Total Asset | 1.67 B | |||
| Retained Earnings | 650.05 M | |||
| Working Capital | 241.85 M | |||
| Current Asset | 288.39 M | |||
| Current Liabilities | 46.54 M | |||
| Net Asset | 1.67 B |
About ABIOMED Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ABIOMED's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABIOMED using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABIOMED based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Consideration for investing in ABIOMED Stock
If you are still planning to invest in ABIOMED check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the ABIOMED's history and understand the potential risks before investing.
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |